TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: -$179.0K2010: -$2.38M2011: -$12.65M2012: -$27.88M2013: $154.93M2014: $206.79M2015: $198.37M2016: $162.24M2017: $129.46M2018: $183.17M2019: $49.77M2020: $50.55M2021: -$79.67M2022: -$16.66M2023: -$136.21M2024: -$186.02M2025: -$292.93M-$292.93M
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$292.93M-57.5%
2024-$186.02M-36.6%
2023-$136.21M-717.8%
2022-$16.66M+79.1%
2021-$79.67M-257.6%
2020$50.55M+1.6%
2019$49.77M-72.8%
2018$183.17M+41.5%
2017$129.46M-20.2%
2016$162.24M-18.2%
2015$198.37M-4.1%
2014$206.79M+33.5%
2013$154.93M+655.8%
2012-$27.88M-120.4%
2011-$12.65M-432.4%
2010-$2.38M-1227.4%
2009-$179.0K—